PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma
PD-1/PD-L1 与 LAG3 联合治疗与转移性原发性肺淋巴上皮瘤样癌中免疫检查点抑制剂的临床活性相关
期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2022.951817
Yu-Min Zhong, Kai Yin, Yu Chen, Zhi Xie, Zhi-Yi Lv, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Bin-Chao Wang, Wen-Zhao Zhong, Ling-Ling Gao, Wen-Bin Zhou, Ji Chen, Hai-Yan Tu, Ri-Qiang Liao, Dong-Kun Zhang, Shui-Lian Zhang, Dan-Xia Lu, Hong-Bo Zheng, Heng-Hui Zhang, Yi-Long Wu, Xu-Chao Zhang